Business Wire

HAI ROBOTICS to Show Its Tallest Robot for the 1st Time in Europe at LogiMAT 2022

Share

HAI ROBOTICS, the pioneer in Autonomous Case-handling Robot (ACR) systems for warehouse logistics, will exhibit its cutting-edge automation technology at LogiMAT 2022, Europe's biggest annual intralogistics tradeshow, from May 31 to June 2 in Stuttgart, Germany.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220522005089/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

HAIPICK A42T can reach a max picking height of 10 meters. (Photo: Business Wire)

The company will show how the ACR systems, a highly flexible goods-to-person solution that improves operation efficiency and storage density, could meet the current needs of Europe's warehouses and distribution centers.

The live demo at Booth D71, Hall 3 will be led by HAIPICK A42T, the tallest robot in HAI ROBOTICS' ACR systems that can reach a max picking height of 10-meters. Featuring a telescopic lift, the robot can also descend to as low as 0.28m to pick totes and cartons stored on the bottom level of the shelf. It can carry 8 loads to feed HAIPORT, goods-to-person workstation, in one move. The robot has been titled the "Best in Intralogistics" in IFOY 2021.

HAIPORT, also to be displayed at LogiMAT, is another warehousing efficiency and throughput booster. With the ability to load four to eight cases in only three seconds from a robot, and unload the same number of cases in five seconds at the same time, a single workstation is able to handle up to 900 cases per hour, an order-fulfillment speed that is 16 times faster than robot-to-conveyor belt transport.

ACR systems, "much more attractive"

HAI ROBOTICS sees the ACR systems a good fit for European users, especially in the age of e-commerce when more consumers are longing for faster deliveries and omni-channel shopping experience.

Mr Kai Ramadhin, the company's VP of Sales & Marketing Europe, said: "HAI ROBOTICS solution provides more flexibility in terms of expansion ability, rapid deployment times and so on. So the sweet-spot of our solution is much more attractive."

Mr Ramadhin noted the company is focused on creating a local network of system integrator, installation and service partners, so that any user of ACR systems can expect rapid and high-quality service wherever they are in Europe.

Since setting up its regional headquarters in the Netherlands in late 2021, HAI ROBOTICS has built a strong localized network in countries of France, Germany, Spain, Italy, the Benelux and the U.K.

The ACR systems are presented by its global partner Savoye at Log!Ville in Belgium in an initiative to make the high-density warehousing technology widely known to the European supply chain. The company has also teamed up with U.K.-based Invar System and Greece's Voyatzoglou Systems to enable tailored service accessible to regional business operators.

When the market gets increasingly dynamic and volatile, the company sees the systems can bring users some key benefits, including:

1. Alleviating labor challenges

Through the automation of practices, warehouses can meet the demands of the modern world by improving employee productivity and filling job vacancies, when recruiting and retaining gets tough.

Robots also free workers from doing repetitive and labour intensive work in the warehouse. The ACR systems, for example, save a worker 40,000 to 60,000 steps of walking per day, on average, according to the company's statistics.

2. Storage space utilization to save land investment

As warehouse ceiling heights have continuously risen, the ACR systems, with the max picking height reaching 10 meters, allow the warehouse to easily use the upper storage space. That may also save the user investment in warehouse expansion, in particular in countries where land costs are high.

3. Fast & flexible implementation, more affordable

Business owners are facing a fast-changing and less predictable market nowadays than ever before. The growing customer expectations for faster deliveries and omni-channel shopping experience are driving companies to rethink their supply-chain operating models. The ACR systems have the high level of flexibility to allow a project to be deployed within months, and can be easily scaled according to business volume. A warehouse owner can choose to scale operation by adding or removing robots without disrupting any ongoing operations since the ACR systems require no structural changes to an existing facility.

That also means the systems are more affordable, especially for smaller businesses.

In Europe, many small-to-medium-sized enterprises see a need for automation, but their limited budget does not allow them to spend years implementing large projects. The ACRs turn out to be a fit in that case too.

ACR systems allow any business to start automation small, and grow as business grows. Many of its subscribers started to customize their solutions with a few robots and adding more when their demand expands.

4. Ideal for the age of e-commerce

In the age of e-commerce, businesses across the globe need to deal with flurries of online orders, which often come scattered and in large numbers. Plus the need to shorten delivery time to improve customer satisfaction, they need to significantly boost the order-fulfilment speed of their warehouses and DCs.

E-grocery emerges to be the channel embracing the growth capabilities. According to McKinsey, e-grocery channel grew by more than 50 percent in 2020 - compared to 2019 growth - for key European markets, creating an even stronger need for efficient e-grocery fulfillment solutions. Smaller unit picks, mixed orders, and a high speed of delivery make e-grocery labor intensive and therefore ideal for automation.

The ACR systems can boost order-fulfillment efficiency when handling large SKU portfolio as well as small orders with a high share of single-unit picks in e-grocery warehouses.

In several micro-fulfillment centers in Europe, the ACR systems have been implemented to handle home-delivery orders as well as click-and-collect orders with contactless deliveries over the counter at the storefront.

ABOUT HAI ROBOTICS

HAI ROBOTICS, the pioneer in Autonomous Case-handling Robot (ACR) systems, is committed to providing efficient, intelligent, flexible, and customized warehouse automation solutions through robotics technology and AI algorithms. It aims to create value for each factory and logistics warehouse. The HAIPICK ACR system, independently developed in 2015, is the world's first of its kind.

Founded in 2016 in Shenzhen, China, HAI ROBOTICS has offices in the U.S., Europe, Japan, Southeast Asia, Australia, Hong Kong and Taiwan, serving customers from more than 30 countries and regions.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Anna Zhao, PR Manager
anna.zhao@hairobotics.com
www.hairobotics.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Caranx Medical announces successful world first robotic assisted transcatheter heart valve implantation in an animal16.4.2024 11:30:00 EEST | Press release

Caranx Medical (‘Caranx’), a French medical device company specializing in the development of autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced the successful world first robotic assisted heart valve (aortic valve) implantation in an animal. The assisted heart valve implantation in the animal was successfully performed by Dr. Stéphane Lopez, Caranx CMO Dr. Eric Sejor, Caranx CTO Pierre Berthet-Rayne and Caranx team. “This groundbreaking achievement is the result of hard teamwork. At Caranx Medical, we are dedicated to improving patients' lives through true innovation. This successful transcatheter robotic aortic valve implantation marks the first step toward a new generation of intelligent robots guided by AI, set to transform healthcare as we know it” says Pierre Berthet-Rayne, PhD, co-founder and CTO of Caranx. “This major medical first lies not only in the technical achievement of Caranx Medical's engine

Arthur D. Little Publishes Human After All – Latest Edition of PRISM Magazine16.4.2024 11:00:00 EEST | Press release

Arthur D. Little (ADL) has published Human After All – the latest edition of its strategy and innovation magazine PRISM. As we enter the era of AI, the first edition of 2024 highlights the importance of taking a human-centric approach to business management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416226137/en/ Arthur D. Little has published Human After All – the latest edition of its strategy and innovation magazine PRISM. (Graphic: Business Wire) The magazine features seven key articles: Optimistic global CEOs focus on people and skills in an AI future - Our lead article shares highlights from the ADL 2024 CEO Insights Study, finding that CEOs are increasingly confident of future economic success. The people-centric lab of the future – how technology and AI can play a key role in driving breakthrough innovation by enabling people to become perfect innovators. The future workforce - Recruiting and retaining vital

Magnesium Capital closes oversubscribed inaugural Fund at €135m hard cap16.4.2024 10:32:00 EEST | Press release

Magnesium Capital, the Energy Transition buyout specialist, is delighted to announce the successful close of its inaugural Fund, Magnesium Capital I, at its hard cap of €135m, exceeding the €100m Fund target. The final close occurred less than a year after the Fund’s first close with Magnesium attracting blue-clip institutional investors from the US, Europe and the UK. Magnesium focuses on profitable European companies with proven technologies or tech-enabled services that are positively impacting the decarbonisation of the production, distribution and consumption of energy. The team has been backing the buyouts of such businesses for a number of years on a direct deal basis. Since inception, Magnesium has completed seven platform investments, signed six follow-on acquisitions and exited two investments for 4.2x gross MOIC. The combined impact of these portfolio companies already directly contributes to the avoidance of over 30 million tonnes of CO2 equivalent per annum. Ian Jones, Man

Money20/20 Europe Unveils 2024 Speaker Lineup Under ‘Human X Machine’ Show Theme16.4.2024 10:00:00 EEST | Press release

Money20/20, the world’s leading fintech show and the place where money does business, unveils its agenda for its upcoming Europe show in Amsterdam, 4-6 June. 350+ speakers are expected to take the stage in Amsterdam this year including C-suite executives from global banks such as Deutsche Bank and ING; fintech players such as Adyen and Revolut, senior representatives from the European Central Bank and the European Commission, and blockchain solution providers such as Ripple. The show promises an amalgamation of expertise, from the Wirecard whistleblower Pav Gill to tech evangelist Prince Constantijn van Oranje-Nassau of the Netherlands. Under the theme of ‘Human X Machine’, Money20/20 Europe 2024 will explore the dynamic relationship between humans and intelligent machines, focusing on how the partnership between artificial and human intelligence will forge a new era in finance. In line with this, Money20/20 Europe also welcomes the CEOs of AI firms including Mistral AI, Datasnipper an

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH00216.4.2024 10:00:00 EEST | Press release

MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease indication Pouchitis. MRM Health’s MH002-PC-201 study was a multi-center, open-label clinical trial in 14 acute Pouchitis (PC) patients at multiple clinical sites in Belgium and Italy. The study was designed to evaluate safety (primary objective), initial efficacy, and mechanistic effects of MH002 over 8 weeks. More information about the trial is available at clinicaltrialsregister.eu. The trial met its primary objective with an excellent safety and tolerability at a fixed dose of 400mg per day over 8 weeks’ administration. Treatment-Emergent Adverse Events (TEAE) reported were predominantly mild and unrelated, and there was no evidence of adverse reactions related to MH002. It also demonstrated initial efficacy in clinically relevant parameters,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye